Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in IntangiblesChange in InventoryGains from Investment SecuritiesNet Debt Issuances and RepaymentsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Cash from Operations: 2022-2023

Historic Cash from Operations for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to -$4.7 million.

  • Mainz Biomed N.V's Cash from Operations rose 1.21% to -$4.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$21.9 million, marking a year-over-year decrease of 48.54%. This contributed to the annual value of -$17.1 million for FY2024, which is 22.10% up from last year.
  • Per Mainz Biomed N.V's latest filing, its Cash from Operations stood at -$4.7 million for Q4 2023, which was up 28.44% from -$6.5 million recorded in Q3 2023.
  • Mainz Biomed N.V's 5-year Cash from Operations high stood at -$2.8 million for Q1 2022, and its period low was -$6.5 million during Q3 2023.
  • In the last 2 years, Mainz Biomed N.V's Cash from Operations had a median value of -$4.7 million in 2022 and averaged -$4.6 million.
  • Within the past 5 years, the most significant YoY rise in Mainz Biomed N.V's Cash from Operations was 1.21% (2023), while the steepest drop was 105.19% (2023).
  • Mainz Biomed N.V's Cash from Operations (Quarterly) stood at -$4.7 million in 2022, then grew by 1.21% to -$4.7 million in 2023.
  • Its Cash from Operations was -$4.7 million in Q4 2023, compared to -$6.5 million in Q3 2023 and -$5.1 million in Q2 2023.